YC-1, a benzyl indazole derivative, stimulates vascular cGMP and inhibits neointima formation Academic Article uri icon


MeSH Major

  • Angioplasty, Balloon
  • Carotid Arteries
  • Cyclic GMP
  • Indazoles
  • Platelet Aggregation Inhibitors
  • Tunica Intima


  • The pathobiologic process of arterial stenosis following balloon angioplasty continues to be an enigmatic problem in clinical settings. This research project investigates the ability of YC-1, a benzyl indazole derivative that sensitizes sGC/cGMP, to stimulate endogenous cGMP and attenuate balloon injury-induced neointima (NI) formation in the rat carotid artery. Northern and Western blot analyses revealed enhanced acute expression of iNOS and inducible heme oxygenase (HO-1) mRNA and protein in the injured artery. The contralateral uninjured artery also demonstrated acute HO-1 mRNA and protein induction without detectable iNOS expression. Perivascular application of YC-1 immediately following injury significantly stimulated acute vessel wall cGMP compared to untreated controls. YC-1 treated sections demonstrated significant reduction in NI area (-74%), NI area/medial wall area (-72%), and NI thickness (-76%) 2 weeks post-injury. These results directly implicate YC-1 as a potent new therapeutic agent capable of reducing post-angioplasty stenosis through endogenous CO- and/or NO-mediated, cGMP-dependent processes.

publication date

  • December 20, 2000



  • Academic Article



  • eng

Digital Object Identifier (DOI)

  • 10.1006/bbrc.2000.3942

PubMed ID

  • 11118339

Additional Document Info

start page

  • 646

end page

  • 52


  • 279


  • 2